Weave Francisco Partners Buyout [What It Changes]

TL;DR

• The Weave Francisco Partners Buyout is the August 18, 2026 all-cash deal for Francisco Partners to take Weave Communications private at about $650 million, or $7.40 a share.

• Independent dental, vet, optometry, and medical offices keep the Weave name and the Lehi, Utah headquarters; ticker WEAV is set to leave the New York Stock Exchange after a stockholder vote and regulatory approval, aimed at Q4 2026.

• The stated use of the new owner's check is more spend on Weave's AI receptionist stack and on payments / revenue-cycle tools that already sit on the front desk.

• A solo clinic should inventory phone routing, reminder texts, card-on-file, and insurance-eligibility writebacks now, because those screens are where a private roadmap will show up first.

Key Takeaways

• Cash is certain for public holders if the deal closes; the product roadmap is not. Weave's board recommended the sale after talking with other parties.

• Weave already books mid-teens revenue growth and ~72% GAAP gross margin. The constraint that broke is public-market valuation, not a collapse in practice demand.

• TrueLark (bought in 2025) and the voice/text AI receptionist are the visible AI bets; payments, bulk collections, and insurance portals are the billing bets.

• Staffing a 2-truck shop, a 10-person agency, or a one-doctor clinic still means answering the phone. If Weave is that phone, this buyout is an operations event, not just a Wall Street headline.

• Map every handoff that leaves Weave (PMS writebacks, missed-call texts, payment plans) so a model swap does not become a rebuild.

What the Weave Francisco Partners Buyout is

The Weave Francisco Partners Buyout is Francisco Partners' August 18, 2026 agreement to acquire Weave Communications, Inc. for about $650 million in cash and take the patient-communication platform private.

If you run a two-truck HVAC shop, a 10-person marketing agency, or a solo dental clinic, the reason to care is concrete: the vendor that answers your published phone number, texts appointment reminders, and texts payment links is getting a new owner who has said the next checks go to AI and billing. That is the same operational stack a small contractor uses when the office line is also the book-a-job line. Missed calls, no-show reminders, and "please pay this balance" texts are not tape problems. They are Tuesday problems. Weave's homepage still pitches an all-in-one communications platform for small business; the buyout does not retire that pitch. It changes who funds it.

As of August 18, 2026, Weave remains public as WEAV. The merger still needs a stockholder vote and regulatory clearance. Until those gates clear, your office number, handsets, and card-on-file tokens keep working under current contracts. The change you can plan for is the roadmap after close: more agentic front-desk software, deeper payments, and a private owner that does not have to explain every quarter to the NYSE tape.

What closed on paper, and what still has to close

Francisco Partners' deal release is the primary write-up of the terms. According to that August 18, 2026 Francisco Partners release, Weave stockholders will receive $7.40 per share in cash, a 34% premium to the August 17, 2026 unaffected close. The same page states an aggregate equity valuation of approximately $650 million, says Weave will keep the Weave name and its Lehi headquarters, and says close is anticipated in the fourth quarter of 2026.

$7.40 per share, a 34% premium is the cash number clinics will never see, but it is the number that tells you the buyer paid up to take the vendor off the public tape. A Yahoo Finance reprint carries the identical $650 million equity value and $7.40 cash price. The Weave newsroom listed the acquisition the same day.

SiliconANGLE's August 18, 2026 report added market-tape context the press release omitted. According to SiliconANGLE, Weave closed announcement day at $7.28 with a $582.5 million market cap after a 32% surge. According to the same SiliconANGLE report, the November 2021 IPO high was $22.40.

CEO Brett White said more than 40,000 locations rely on Weave and that the partnership is meant to "enhance our ability to invest in our AI platform, deepen our payments and revenue cycle management capabilities." Board chair Stuart C. Harvey Jr. said the board ran a strategic-alternatives process, spoke with strategic and financial parties, and unanimously recommends the cash deal. Francisco Partners co-president Ezra Perlman said Weave "sits at the center of how tens of thousands of practices communicate with their patients and collect revenue." Principal Nick Nelson added that the thesis is continued product innovation, not a teardown. As of the agreement date, no Weave executive had signed a rollover or co-invest deal with the buyer.

Jefferies LLC is Weave's exclusive financial advisor; Orrick, Herrington & Sutcliffe LLP is Weave's counsel; Kirkland & Ellis LLP is counsel to Francisco Partners. Weave said it will file a proxy for a special meeting and pointed holders to its SEC filings library.

The remaining gates are ordinary for a deal this size. Weave named "required regulatory approvals." The FTC's Hart-Scott-Rodino premerger program is how U.S. agencies review large mergers before they close; parties that must file cannot close until the waiting period runs or is terminated. This hub does not claim a filing date, because none was on the pages opened for this piece.

Sources: Francisco Partners deal release; SiliconANGLE.

Who is writing the next checks

Francisco Partners is a technology-focused private equity firm. According to Francisco Partners' July 23, 2026 fund close, the firm closed $21 billion across Francisco Partners VIII and Agility IV, bringing total capital raised to more than $75 billion, and has invested in more than 500 technology companies since inception.

That dry powder matters to a clinic only because it is the budget behind White's "invest in our AI platform" line. The firm's healthcare software pattern is already on the record. According to Fierce Healthcare, Francisco Partners planned to buy AdvancedMD from Global Payments for $1.125 billion in November 2024. AdvancedMD, like Weave, sells cloud practice software to small and mid-size ambulatory offices.

Private ownership removes the quarterly public-earnings theater. It does not remove the need to collect. A PE owner that just paid a 34% premium has a reason to push payments attach, AI attach, and multi-location attach. Independent practices should expect more packaging of Weave Payments, Weave AI, and TrueLark as the default bundle, not as optional add-ons that sit quietly on a price sheet.

The operating company behind the ticker

Weave was founded in 2008. Investor relations still describes an all-in-one customer-experience and payments platform for small and medium-sized healthcare businesses, with growth vectors in specialty medical verticals, integration partnerships, multi-location practices, payments, and AI.

According to Weave's February 19, 2026 full-year 2025 results, full-year total revenue was $239.0 million, up 17.0% from $204.3 million in 2024. That same release lists 39,625 customer locations at year-end 2025 after 4,628 net new locations, dollar-based net retention of 93%, dollar-based gross retention of 89%, $81.7 million of cash and short-term investments, $12.9 million of full-year free cash flow, and a GAAP operating loss of $30.6 million against $4.1 million of non-GAAP operating income.

$239.0 million full-year 2025 revenue is the scale the $650 million check is buying. It is not a distressed wind-down. It is a growing, still-unprofitable-on-GAAP vertical software company whose public multiple lagged its growth.

According to Weave's April 30, 2026 first-quarter results, first-quarter total revenue was $65.5 million, up 17.4% from $55.8 million a year earlier. GAAP gross margin was 72.6%. GAAP operating loss was $6.0 million; non-GAAP operating income was $2.5 million. The same Q1 release guided full-year 2026 revenue to $275.0–$278.0 million and non-GAAP operating income to $10.5–$13.5 million, and it hosted a conference-call event page for April 30, 2026.

CEO White said on that Q1 print that over 50% of customer locations were using the AI tools embedded in the platform, and that an omnichannel AI receptionist for voice and text was coming. The Q1 highlights also named G2's 2026 Best Software Awards (#2 on Best Healthcare Software Products), exclusive ADA-endorsed patient-engagement status announced to 152,000 members, Private Communications inboxes, and bulk collections writebacks for Dentrix Enterprise, Fuse, and Eaglesoft plus payment writebacks for Athena, NexTech Health, and NT Practice+. The year-end 2025 letter had put the ADA member universe at 160,000; both figures are Weave's, not a confirmation posted on the American Dental Association homepage at the time of writing.

Sources: Weave FY 2025 results; Weave Q1 2026 results.

USTA analysis: implied multiple and cash premium

USTA analysis (derived only from figures cited above; inputs are restated so you can check the arithmetic):

Inputs: $650 million equity value from the Francisco Partners release; $239.0 million FY 2025 revenue from Weave's FY 2025 results; $7.40 cash per share and a 34% premium from the same Francisco Partners release; $35 million TrueLark consideration from Utah Business; $1.125 billion AdvancedMD value from Fierce Healthcare.

USTA analysis. Sources for inputs: Francisco Partners; Weave FY 2025 results; Utah Business / TrueLark; Fierce Healthcare / AdvancedMD.

A 2.72x equity-to-last-year-revenue take-private is the math of a public company that was growing 17% with 72% GAAP gross margin and still trading as if AI would eat its subscription. That is the "why now": the public tape was not paying for the AI build, and a specialist healthcare-software buyer was willing to. It is not a clinic-side demand crash. The $1.88-per-share cash premium is what public holders are being paid to sell the future AI and RCM upside. Clinics do not receive that $1.88. They receive whatever product the new owner ships with that upside thesis.

What the AI and payments cash is pointed at

The product surfaces a dental or vet office actually touches are already named on Weave's site, and they are the surfaces a private owner can reprice or rebundle.

Weave Phones put caller name, upcoming appointments, balances, and tasks on the handset, then add missed-call text, multi-location routing, and Yealink hardware. The phones page states that offices save up to two hours a day following up on missed calls, on average as reported by Weave customers. Weave Reminders send text, call, or email confirmations and update the calendar from the reply; that page states offices using Weave see 9 more on-time patients per week, on average as reported by Weave customers. Weave Scheduling adds online requests, waitlist, reactivation, and post-visit follow-ups — the same jobs covered in our notes on appointment reminder software for dental practices and on text follow-up for veterinary clinics.

Weave Texting is the two-way office-number channel: missed-call text, missed-text auto-reply, bulk reactivation, and after-hours Text Connect. If you already automate post-visit sequences, see post-visit follow-up for veterinary clinics.

Weave Payments is the collections layer the CEO flagged: text-to-pay, online bill pay, payment plans, terminals, tap-to-pay, card on file, ACH, digital wallets, Affirm, CareCredit, surcharging, scheduling deposits, and bulk collections for Dentrix Enterprise, Fuse, and Eaglesoft. The payments page states that 83% of offices that use Weave Payments collect faster, on average as reported by Weave customers.

Insurance verification is the dental-specific RCM wedge: portal pulls with a stated 90% successful verification rate on average (results may vary), a payer database Weave said grew 50% as of February 2025, and writebacks into the PMS. That is the "deepen revenue cycle" half of White's quote, sitting next to the same operational pain we mapped in the dental and medspa automation ROI analysis.

TrueLark is the AI receptionist Weave already bought. According to Utah Business, Weave agreed in May 2025 to acquire TrueLark for $35 million ($25 million cash and $10 million equity), aimed at 24/7 missed-call, SMS, and web-chat booking for multi-location and DSO-style groups. Weave's TrueLark product page states that practices miss 20–30% of calls and that 75% of those callers never try again. Weave AI lists a voice AI receptionist in early access, text conversations via TrueLark, Call Intelligence, and HIPAA-compliant infrastructure, and it states that over 35,000 locations use Weave for unified communications and AI-powered automations.

Over 50% of locations using Weave AI is the attach rate White put on the Q1 2026 print, linked above. That is already majority adoption of some AI feature. The buyout cash is aimed at making the receptionist the default teammate, not a beta toggle.

None of this sits outside privacy law. The HHS HIPAA Privacy Rule sets national standards for protected health information. Weave's security page states TLS 1.2+ in transit, AES-128 or better at rest, Google Cloud hosting, HIPAA-supportive product design, and MFA on internal systems. A private-equity close does not waive those duties.

Practices that already route missed-call texts and reminder exceptions through US Tech Automations can treat a new Weave AI receptionist as another intake channel instead of ripping out the rest of the stack.

Sources: Weave Phones; Reminders; Payments; Insurance verification; TrueLark; Q1 2026 results.

What a clinic should inventory before Q4 2026

Do this as a checklist, not as a panic. The deal has not closed. Your number should still ring.

Export or screenshot today's call-routing tree, after-hours greeting, and missed-call text. Those are the first things an AI receptionist will overlay. If referral tracking or controlled-substance log workflows live in a different system, write down where Weave stops and the other system starts.

List every PMS writeback you depend on (Dentrix, Eaglesoft, Fuse, Athena, and the rest named in Q1). A private owner can prioritize DSO and multi-location connectors; a one-doctor office should know which writebacks are load-bearing.

Pull a 30-day sample of payment links, failed cards, and CareCredit offers. If bulk collections or writebacks change after close, keep US Tech Automations on the payment-follow-up path so statements still go out while staff learn the new screens.

Confirm who at the practice can approve a number port, a new AI voice, or a HIPAA business-associate update. The HHS Privacy Rule does not pause for a merger. None of that requires you to switch vendors the week of the announcement. It requires you to know which three jobs cannot break: answer the phone, fill the chair, collect the balance.

Signal vs Speculation

Signal (sourced, as of August 18, 2026 unless dated otherwise): Francisco Partners signed a definitive agreement to buy Weave at about $650 million, or $7.40 a share in cash, a 34% premium to the August 17 close. The board was unanimous. Headquarters stays in Lehi. The Weave name stays. Close is aimed at Q4 2026, subject to a stockholder vote and regulatory approvals. Weave did $239.0 million of revenue in 2025 and $65.5 million in Q1 2026, both up 17% year over year. Locations were 39,625 at year-end 2025; White said more than 40,000 on announcement day. TrueLark was a $35 million 2025 purchase. Francisco Partners had already underwritten AdvancedMD at $1.125 billion in 2024 and closed $21 billion of new funds in July 2026. No executive rollover was in place on signing day.

Speculation (our read, 12–36 months, not a promise): Our read: if the deal closes on the stated terms, independent clinics should expect faster packaging of the AI receptionist with phones and texting, and more pressure to run payments inside Weave rather than on a standalone processor. Our read: if X holds — X being PE's need to earn a return on a 2.72x equity/revenue check — then multi-location groups and DSOs get the first new features, because that is where TrueLark was already aimed. Our read: a one-location practice will not lose dial tone on close day, but it may see price, bundle, and "AI included" language shift at the next renewal. Our read: if regulatory review stretches past Q4 2026, the public company keeps reporting and the AI receptionist still ships on the Q1 2026 promise, just without the private-capital shield. We do not forecast a shutdown, a forced migration off Weave, or a guaranteed cut in per-location price. Those outcomes were not in the documents we opened.

Frequently asked questions

Does the Weave Francisco Partners Buyout change my office phone number?

No sourced document says numbers port or die on announcement day. Weave Phones and texting still describe the same office-number model. Watch your next MSA or BAA amendment, not the press release, for any number-port language.

When does Weave stop trading on the NYSE?

Upon completion, per the Francisco Partners release. Completion is anticipated in Q4 2026 and still requires a stockholder vote and regulatory approvals. Until then, WEAV remains a NYSE-listed ticker.

Will TrueLark and the AI receptionist still ship?

White's Q1 2026 remarks and the deal quotes both point at more AI investment, not a kill. TrueLark is already a live product page; the voice receptionist is listed as early access on Weave AI. A private owner can still change sequencing after close.

What happens to payments and insurance verification?

They are named as the other half of the investment thesis. Weave Payments and insurance verification are live today, including bulk collections for several dental PMS systems. Expect more attach, not an immediate rip-out.

Do I have to sign a new contract the day the deal is announced?

No source we opened requires that. The company continues to operate under the Weave name. New paper, if any, would show up in a renewal, an order form, or a BAA update after close.

How should a multi-location dental group prepare?

Inventory routing, writebacks, and payments per location. TrueLark's 2025 pitch was explicitly multi-location and DSO. Align that inventory with the dental automation ROI baseline so you can tell whether a new AI receptionist is filling chairs or just adding another inbox.

Glossary

• Weave Francisco Partners Buyout — The August 18, 2026 all-cash agreement for Francisco Partners to acquire Weave Communications at about $650 million and take it private.

• Take-private — A merger that ends a public listing; Weave said WEAV will cease to trade on the NYSE at completion.

• Unaffected close — The August 17, 2026 closing price used as the 34% premium baseline, before the announcement moved the tape.

• Revenue cycle management (RCM) — The billing path from eligibility check to payment; Weave named payments and RCM as a use of the new capital.

• Agentic AI receptionist — Software that books, answers FAQs, and hands off to staff over voice or text without a human on every turn; TrueLark plus Weave's voice agent.

• Writeback — An automatic update from Weave into a practice-management system (balances, eligibility, payments).

• HSR waiting period — The Hart-Scott-Rodino review window that can apply to large U.S. mergers before they close.

• Dollar-based net retention — Weave reported 93% NRR as of December 31, 2025; a measure of expansion versus churn in existing accounts.

The buyout is a change of owner for the software that already sits between a patient and a chair. Map those handoffs in US Tech Automations before the Q4 2026 close window, then open the agentic workflow catalog if you want those phone, reminder, and collections steps on a single path. More of the same-industry library sits on the homepage.